Back to 
Rathbones Group PLC
Rathbones Group PLC
SMMT
Showing 0 of 3 quarters
Position history for Rathbones Group PLC's holdings in Summit Therapeutics Inc.
No. Rathbones Group exited its SMMT (Summit Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 30,317 shares worth $79,127. Rathbones Group first reported SMMT in Q3 2023 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.